BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Junqueira C, Crespo Â, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, Ho F, Beakes C, Margolin J, Russell N, Kays K, Boucau J, Das Adhikari U, Vora SM, Leger V, Gehrke L, Henderson LA, Janssen E, Kwon D, Sander C, Abraham J, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Filbin MR, Lieberman J. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 2022. [PMID: 35385861 DOI: 10.1038/s41586-022-04702-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 41] [Article Influence: 80.0] [Reference Citation Analysis]
Number Citing Articles
1 Brewer RC, Robinson WH, Lanz TV. SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-01112-w] [Reference Citation Analysis]
2 Richards A, Friesen M, Khalil A, Barrasa MI, Gehrke L, Jaenisch R. SARS-CoV-2 infection of human pluripotent stem cell-derived liver organoids reveals potential mechanisms of liver pathology. iScience 2022;25:105146. [PMID: 36128218 DOI: 10.1016/j.isci.2022.105146] [Reference Citation Analysis]
3 Halajian EA, Leblanc EV, Gee K, Colpitts CC. Activation of TLR4 by viral glycoproteins: A double-edged sword? Front Microbiol 2022;13:1007081. [DOI: 10.3389/fmicb.2022.1007081] [Reference Citation Analysis]
4 Boldova AE, Korobkin JD, Nechipurenko YD, Sveshnikova AN. Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19. IJMS 2022;23:11364. [DOI: 10.3390/ijms231911364] [Reference Citation Analysis]
5 Martínez-Colón GJ, Ratnasiri K, Chen H, Jiang S, Zanley E, Rustagi A, Verma R, Chen H, Andrews JR, Mertz KD, Tzankov A, Azagury D, Boyd J, Nolan GP, Schürch CM, Matter MS, Blish CA, McLaughlin TL. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci Transl Med 2022;:eabm9151. [PMID: 36137009 DOI: 10.1126/scitranslmed.abm9151] [Reference Citation Analysis]
6 Yin H, Huang Z, Niu S, Ming L, Jiang H, Gu L, Huang W, Xie J, He Y, Zhang C. 5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis. Front Immunol 2022;13:967921. [DOI: 10.3389/fimmu.2022.967921] [Reference Citation Analysis]
7 de Almeida L, da Silva ALN, Rodrigues TS, Oliveira S, Ishimoto AY, Seribelli AA, Becerra A, Andrade WA, Ataide MA, Caetano CCS, de Sá KSG, Pelisson N, Martins RB, de Paula Souza J, Arruda E, Batah SS, Castro R, Frantz FG, Cunha FQ, Cunha TM, Fabro AT, Cunha LD, Louzada-junior P, de Oliveira RDR, Zamboni DS. Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection. Sci Adv 2022;8:eabo5400. [DOI: 10.1126/sciadv.abo5400] [Reference Citation Analysis]
8 Bertoletti A, Le Bert N, Tan AT. Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization. IJMS 2022;23:10679. [DOI: 10.3390/ijms231810679] [Reference Citation Analysis]
9 López-martínez R, Albaiceta GM, Amado-rodríguez L, Gómez J, Cuesta-llavona E, García-clemente M, Hermida-valverde T, Enríquez-rodriguez AI, Hernández-gonzález C, Martínez-borra J, López-larrea C, Gil-peña H, Alvarez V, Coto E. IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort. Genes Immun. [DOI: 10.1038/s41435-022-00179-3] [Reference Citation Analysis]
10 Yao Y, Subedi K, Liu T, Khalasawi N, Pretto-kernahan CD, Wotring JW, Wang J, Yin C, Jiang A, Fu C, Dimitrion P, Li J, Veenstra J, Yi Q, Mckinnon K, Mckinnon JE, Sexton JZ, Zhou L, Mi Q. Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes. Cell Discov 2022;8. [DOI: 10.1038/s41421-022-00453-8] [Reference Citation Analysis]
11 Spracklen TF, Mendelsohn SC, Butters C, Facey-thomas H, Stander R, Abrahams D, Erasmus M, Baguma R, Day J, Scott C, Zühlke LJ, Kassiotis G, Scriba TJ, Webb K. IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort. Front Immunol 2022;13:992022. [DOI: 10.3389/fimmu.2022.992022] [Reference Citation Analysis]
12 Gatineau J, Nidercorne C, Dupont A, Puiffe M, Cohen JL, Molinier-frenkel V, Niedergang F, Castellano F. IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike. Front Immunol 2022;13:982839. [DOI: 10.3389/fimmu.2022.982839] [Reference Citation Analysis]
13 Latifi-pupovci H. Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies. Biomedicine & Pharmacotherapy 2022;153:113368. [DOI: 10.1016/j.biopha.2022.113368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Oosterhoff JJ, Larsen MD, van der Schoot CE, Vidarsson G. Afucosylated IgG responses in humans - structural clues to the regulation of humoral immunity. Trends Immunol 2022:S1471-4906(22)00161-2. [PMID: 36008258 DOI: 10.1016/j.it.2022.08.001] [Reference Citation Analysis]
15 Amormino C, Tedeschi V, Paldino G, Arcieri S, Fiorillo MT, Paiardini A, Tuosto L, Kunkl M. SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-like Inflammatory Activity. Cells 2022;11:2526. [DOI: 10.3390/cells11162526] [Reference Citation Analysis]
16 Giannella A, Riccetti S, Sinigaglia A, Piubelli C, Razzaboni E, Di Battista P, Agostini M, Dal Molin E, Manganelli R, Gobbi F, Ceolotto G, Barzon L. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients. Front Immunol 2022;13:968991. [DOI: 10.3389/fimmu.2022.968991] [Reference Citation Analysis]
17 Bigay J, Le Grand R, Martinon F, Maisonnasse P. Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development. Front Microbiol 2022;13:932408. [DOI: 10.3389/fmicb.2022.932408] [Reference Citation Analysis]
18 Chen M, Ma Y, Chang W. SARS-CoV-2 and the Nucleus. Int J Biol Sci 2022;18:4731-43. [PMID: 35874947 DOI: 10.7150/ijbs.72482] [Reference Citation Analysis]
19 Chen Y, Xu Y, Zhang K, Shen L, Deng M. Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target. Front Cell Infect Microbiol 2022;12:922511. [DOI: 10.3389/fcimb.2022.922511] [Reference Citation Analysis]
20 Van der Sluis RM, Holm CK, Jakobsen MR. Plasmacytoid dendritic cells during COVID-19: Ally or adversary? Cell Rep 2022;40:111148. [PMID: 35858624 DOI: 10.1016/j.celrep.2022.111148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kolb P, Giese S, Voll RE, Hengel H, Falcone V. Immune complexes as culprits of immunopathology in severe COVID-19. Med Microbiol Immunol. [DOI: 10.1007/s00430-022-00743-8] [Reference Citation Analysis]
22 Hernandez AV, Piscoya A, Pasupuleti V, Phan MT, Julakanti S, Khen P, Roman YM, Carranza-Tamayo CO, Escobedo AA, White CM. Beneficial and harmful effects of monoclonal antibodies for the treatment and prophylaxis of COVID-19: a systematic review and meta-analysis of randomized controlled trials. Am J Med 2022:S0002-9343(22)00525-3. [PMID: 35878688 DOI: 10.1016/j.amjmed.2022.06.019] [Reference Citation Analysis]
23 Xia S, Wang L, Zhu Y, Lu L, Jiang S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal Transduct Target Ther 2022;7:241. [PMID: 35853878 DOI: 10.1038/s41392-022-01105-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
24 Tang Y, Zhang P, Liu Q, Cao L, Xu J. Pyroptotic Patterns in Blood Leukocytes Predict Disease Severity and Outcome in COVID-19 Patients. Front Immunol 2022;13:888661. [DOI: 10.3389/fimmu.2022.888661] [Reference Citation Analysis]
25 Bertoletti A, Iannacone M. Editorial overview: Viral pathogenesis. Curr Opin Virol 2022;55:101253. [PMID: 35810670 DOI: 10.1016/j.coviro.2022.101253] [Reference Citation Analysis]
26 Theobald SJ, Simonis A, Mudler JM, Göbel U, Acton R, Kohlhas V, Albert MC, Hellmann AM, Malin JJ, Winter S, Hallek M, Walczak H, Nguyen PH, Koch M, Rybniker J. Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination. EMBO Mol Med 2022;:e15888. [PMID: 35785445 DOI: 10.15252/emmm.202215888] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Magnani L, Colantuoni M, Mortellaro A. Gasdermins: New Therapeutic Targets in Host Defense, Inflammatory Diseases, and Cancer. Front Immunol 2022;13:898298. [DOI: 10.3389/fimmu.2022.898298] [Reference Citation Analysis]
28 . Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. The Lancet Respiratory Medicine 2022. [DOI: 10.1016/s2213-2600(22)00215-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Qi H, Liu B, Wang X, Zhang L. The humoral response and antibodies against SARS-CoV-2 infection. Nat Immunol 2022;23:1008-20. [PMID: 35761083 DOI: 10.1038/s41590-022-01248-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Natale NR, Lukens JR, Petri WA Jr. The nervous system during COVID-19: Caught in the crossfire. Immunol Rev 2022. [PMID: 35770683 DOI: 10.1111/imr.13114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol 2022;76:102608. [PMID: 35863101 DOI: 10.1016/j.conb.2022.102608] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Stokel-Walker C. How long does SARS-CoV-2 stay in the body? BMJ 2022;377:o1555. [PMID: 35764342 DOI: 10.1136/bmj.o1555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 García-Villalba J, Hurtado-Navarro L, Peñín-Franch A, Molina-López C, Martínez-Alarcón L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol 2022;13:894470. [PMID: 35663992 DOI: 10.3389/fimmu.2022.894470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Anaya JM, Herrán M, Beltrán S, Rojas M. Is post-COVID syndrome an autoimmune disease? Expert Rev Clin Immunol 2022. [PMID: 35658801 DOI: 10.1080/1744666X.2022.2085561] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Declercq J, De Leeuw E, Lambrecht BN. Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: From prognostic marker to therapeutic agent. Cytokine 2022. [DOI: 10.1016/j.cyto.2022.155934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Sathiavageesan S, Sundaram V, Sundaram N, Shanmugam VB, Selvaraj J, Vivek N, Ravi GK, Velan M, Palaniappan C, Singaravelu V, Shanmugam MP. Fulminant onset COVID-19: predictors and outcome. Postgrad Med J 2022:postgradmedj-2022-141724. [PMID: 35537807 DOI: 10.1136/postgradmedj-2022-141724] [Reference Citation Analysis]
37 Pérez-gómez HR, Morfín-otero R, González-díaz E, Esparza-ahumada S, León-garnica G, Rodríguez-noriega E. The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic. Pathogens 2022;11:556. [DOI: 10.3390/pathogens11050556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Gaikwad H, Li Y, Wang G, Li R, Dai S, Rester C, Kedl R, Saba L, Banda NK, Scheinman RI, Patrick C, Mallela KMG, Moghimi SM, Simberg D. Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-like" Nanoparticles. ACS Nano 2022. [PMID: 35507641 DOI: 10.1021/acsnano.2c02794] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Selva KJ, Chung AW. Insights into how SARS-CoV2 infection induces cytokine storms. Trends in Immunology 2022. [DOI: 10.1016/j.it.2022.04.007] [Reference Citation Analysis]
40 Suryavanshi SV, Zaiachuk M, Pryimak N, Kovalchuk I, Kovalchuk O. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro. Cells 2022;11:1391. [DOI: 10.3390/cells11091391] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Mallapaty S. What triggers severe COVID? Infected immune cells hold clues. Nature 2022. [PMID: 35388153 DOI: 10.1038/d41586-022-00965-z] [Reference Citation Analysis]